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Abstract A simple and effective methodology is proposed for 
direct expression of PCR-generated linear DNAs in cell-free 
transcription/translation systems without cloning DNA frag- 
ments in plasmids. This methodology is realized for the synthesis 
of the active antibacterial peptide cecropin using the synthetic 
coding sequence. Possible scientific applications and perspectives 
of the proposed approach are discussed. 
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1. Introduction 
Translat ion in cell-flee systems is commonly used in studies 
of protein biosynthesis mechanisms over a long period of 
time. During the last decade cell-free protein synthesis ystems 
have been proposed for biotechnological applications [1 5]. 
These systems are based either on translation of isolated or 
in vitro presynthesized mRNA,  or on combined transcription/ 
translation where ribosomes use nascent mRNA transcribed 
from a plasmid or an isolated gene by endogenous (cellular) 
or exogenous (e.g. phage) RNA polymerases. 
In most reported cases the genes for mRNA product ion 
were isolated from cells and cloned for expression. A fully 
cell-flee format including initial chemical synthesis of a gene 
and its PCR amplification with subsequent direct expression 
in a cell-flee transcript ion/translat ion system was first pro- 
posed by one of us (A.S.S.) several years ago [1]. Here we 
report on the practical realization of this way for the synthesis 
of cecropin, an antibacterial peptide of 31 amino acid residues 
in length. In no step did living cells participate in the process. 
2. Materials and methods 
2.1. Primers 
All oligonucleotides were synthesized by 'Gene Assembler Plus' 
(Pharmacia). 
Primer Prl: 5'-CCCGCGCATGGGCTCTTGGCTGT-3'; its 5'- 
end contains nucleotides (underlined) complementary to the 3'-end 
sequence of the cecropin-coding region and the ATG triplet. 
Primer Pr2: 5'-AGCCCATGCGCGGGCCGCCCT-3'; it has the 
5'-end sequence complementary to the 5'-end coding region with 
the ATG codon (underlined) of the synthetic gene, but the stop codon 
is excluded. 
Megaprimer (163 nt) containing regulatory elements for efficient 
expression of genes (the T7 promoter, the slO leader and Shine-Dal- 
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garno sequences [6], as well as the additional 45 nt sequence upstream 
of the T7 promoter) and with its 3'-end complementary to the begin- 
ning of the cecropin gene was obtained by PCR from plasmid 
pET21d(+) (Novagen) carrying the synthetic ecropin gene [7]. Two 
primers, Pr3: 5'-CGGCCACGATGCGTCCGGCGTAGA-3' (up- 
stream of the T7 promoter) and Pr4: 5'-GCAGTTTTAGACAGC- 
CAAGAGCCCATG-3', possessing the 5'-end sequence of the cecro- 
pin-coding region with the ATG triplet at its 3'-end, were used for 
this purpose. 
Primer Pr5 with the stop codon at the 3'-end of the cecropin gene 
was prepared earlier for the gene construction [7]. 
2.2. PCR technique 
PCR for the megaprimer synthesis was carried out for 25 cycles of 
1 min at 92°C, 1 min at 54°C and 0.3 min at 72°C, with 0.7 lamol each 
of primers Pr3 and Pr4, in 100 ~tl reaction volume containing 10 mM 
KCI, 20 mM Tris-HC1 (pH 8.8 at 25°C), 10 mM (NH4)2SO4, 2 mM 
MgSO4, 0.1% Triton X-100, 0.2 mM each dNTP, 250 ng plasmid and 
2 U Vent DNA polymerase (NEB). Multimeric cecropin genes were 
obtained with Prl and Pr2 in a similar way. A 5 ~tl aliquot of multi- 
meric cecropin genes was subjected to PCR as a template with 0.5 lag 
of the megaprimer and 0.7 I.tmol of primer Pr5 for 25 cycles of 1 min 
at 90°C, 30 s at 54°C, 1 min at 72°C each with 2.5 U of the Taq DNA 
polymerase. The reaction conditions were the same as in the previous 
amplification procedure. The final multimeric PCR product was iso- 
lated by Wizard PCR purification resin (Promega). 
2.3. Plasmid construction 
The multimeric PCR product treated with the NcoI and EcoRI 
enzymes (BION, Moscow) was cloned in the pET21d(+) plasmid (No- 
vagen, USA). Transformed cells were analyzed with restriction en- 
zymes. The isolated plasmid with a dimeric cecropin gene was used 
in the transcription/translation system as a control experiment. 
2.4. Expression i vitro 
Experiments on the in vitro expression were carried out in the tran- 
scription/translation system based on the Escherichia coli MRE 600 
$30 extract supplemented with the T7 phage RNA polymerase [8]. 
The reaction mixture contained 50 units RNasin, 100 units T7 polym- 
erase, 20 /aM [14C]Leu (282 Ci/mol) (Amersham), 1/10 volume $30 
extract, 100 ~M of each amino acid and 1 mM of each NTP. A 20 
lal aliquot of the PCR reaction mixture corresponding to 0.5 1 ~tg of 
the DNA synthesized was added to 50 ~tl reaction volume. In the 
control expression experiment 1 lag of plasmid with the dimeric ecro- 
pin gene was used in the same translation mixture. 10 lal aliquots were 
taken at consecutive time points for the estimation of [14C]Leu incor- 
poration into hot TCA insoluble material. Synthesized products were 
also analyzed by PAGE [9] followed by autoradiography. 
2.5. Activity assay 
Antibacterial activity was tested by the growth zone inhibition as- 
say using E. coli strain D21 [10]. Multimeric cecropin products were 
cleaved with BrCN to produce active monomeric ecropin. For that 
purpose 200/al of the translation mixture was clarified by centrifuga- 
tion, dialyzed against 5 mM NaH2PO4fNa2HPO4 buffer (pH 7.4), 
dried and solved in 70% CH3COOH. After the addition of 0.5 mg 
BrCN the mixture was incubated overnight in the dark. Then the 
mixture was diluted 10-fold with distilled water, dried and dissolved 
in 20 ~tl water. 10 ~tl aliquots were applied to the bacterial lawn. 
As a negative control, the same procedure was applied except no 
cecropin-encoding DNA was added to the translation system. 
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Fig. 1. General scheme of DNA construction for its cell-free expression (see Section 2). 
3. Results 
3.1. Production qf multimeric gene construct with 
5'- and 3'-eh, ments 
The fi~llowing DNA sequence coding for cecropin 
25 50  
GATCCATGGGCTCTTGGCTGTCTAAAACTGCGAAAAAACTGGAAAACTCTGCGAAAAAA 
75 100 
CGCATCTCTGAAGGCATCGCGATCGCGATCCAGGGCGGCCCGCGCTAAG 
was deduced from the amino acid sequence of cecropin 
(SWLSKTAKKLENSAKKRISEGIAIAIQGGPR),  and the 
DNA fragment was synthesized earlier [7] (ATG and stop 
codons are underlined). 
A set of multimeric ecropin genes was obtained by the 
modified splicing overlap extension technique [11] with the 
use of primers Prl and Pr2. A conceptually similar procedure 
to polymerize DNA fragments encoding decapeptides was 
published recently [12]. Using primer Pr2, the ATG codon 
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Fig. 2. Synthesis of cecropin in cell-free transcription/translation sys- 
tems: (1) direct expression of PCR product (multimeric cecropin 
genes); (2) expression of plasmid with dimeric cecropin gene. 
for Met was inserted and the stop codon TAA excluded to 
produce a tandemly repeated cecropin gene without stop co- 
dons inside the linear DNA fragment (Fig. 1). 
The long primer (megaprimer) containing the T7 promoter 
and the ribosome binding site (RBS) with the slO leader and 
Shine-Dalgarno sequences was generated by PCR from plas- 
mid pET21d(+) [7] with the use of primers Pr3 and Pr4. The 
megaprimer and primer Pr5 were added to the products of the 
first PCR, containing up to seven repeats of the cecropin 
coding sequence [11], and the next PCR round resulted in 
production of the linear DNA with necessary elements for 
direct expression in a cell-free system (Fig. 1). 
3.2. Direct PCR product expression 
Unpurified PCR mixture (preliminarily concentrated in 
some experiments) was added to the E. coli $30 extract with 
the T7 RNA polymerase for direct expression of the synthe- 
sized DNA fragments in a cell-free transcription/translation 
system. The cecropin yield was up to ca. 3 nmol/ml (calculated 
for monomeric ecropin) (Fig. 2). For comparison, the DNA 
fragment encoding dimeric cecropin cloned in plasmid and 
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Fig. 3. Gel electrophoresis of the cell-flee transcription/translation 
products: radioautography of the polypeptides synthesized (1) in the 
plasmid-directed system (dimeric cecropin), and (2) in the PCR 
product-directed system after CNBr cleavage Imonomeric cecropin). 
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Fig. 4. Cecropin activity assay. Translation mixtures after CNBr 
cleavage of the polypeptide product were tested (see Section 2.5). 
expressed at the same conditions gave 2.1 nmol/ml (Fig. 2). 
Gel electrophoresis proved the formation of a product with 
the expected molecular weight (Fig. 3). 
3.3. Antibacterial activity of the translation product 
Earlier it was shown that dimeric cecropin synthesized in 
the plasmid-programmed c ll-free system is not active [11], at 
least at concentrations where monomeric ecropin displays 
activity. Since the active cecropin molecule does not contain 
methionine, the multimeric polypeptide produced in the cell- 
free system could be subjected to CNBr cleavage. After cleav- 
age of the translation product, the antibacterial ctivity was 
clearly displayed in the cell growth inhibition test (Fig. 4). 
4. Discussion 
Earlier the DNA fragment encoding several antibacterial 
peptides, including cecropin, was synthesized, cloned in plas- 
mid and expressed both in vivo and in vitro [7]. The yield of 
cecropin in the E. coli cell-free transcription/translation sys-
tem from the monomeric synthetic gene cloned in plasmid was 
800 pmol/ml. The expression of the DNA fragment encoding 
dimeric ecropin molecules cloned in plasmid gives 2100 pmol/ 
ml of cecropin monomer. Direct PCR product expression pro- 
duces up to 3050 pmol/ml of cecropin calculated per mono- 
mer. Since genetic elements at the 5'- and 3'-ends are the same 
in all the constructs used, obvious reasons for the best results 
in the case of direct expression f the PCR products can be 
the stability of the multimeric gene, the multimeric mRNA 
and/or the multimeric polypeptide product synthesized in 
the cell-free system. This finding correlates with the fact that 
cecropin fused to protein A could be successfully synthesized 
in vivo [7]. We believe that our PCR constructs can be further 
improved by addition of a stable structural element at the 3'- 
end of the gene in order to impede 3'-exonucleolytic degrada- 
tion. Such elements can be introduced with the downstream 
primer in the last round of PCR. 
The proposed approach can be used for direct in vitro ex- 
pression of polypeptides and proteins that are unstable in 
living cells, or proteins that are strongly cytotoxic. By this 
method PCR-generated copies and/or multi-copies of genes 
and their fragments from genomic libraries (or genomic 
DNA) can be directly expressed in a transcription/translation 
system and then tested, without subcloning procedures. In 
particular, in vitro expression of DNA fragments with open 
reading frames for the purpose of protein identification, or 
test expression of some genes before construction of special 
vectors could be useful applications of the methodology re- 
ported here. 
It is expected that the yield of polypeptides synthesized in 
this way can be increased several times in continuous flow 
cell-free (CFCF) expression systems [13] (see also [14,8]). A 
simplified version of the CFCF system, the so-called CECF 
(continuous exchange cell-free) system, where an exchange of 
substrates and products through a dialysis membrane is used 
instead of a continuous flow [14], may also be promising. 
Multimeric DNA sequences encoding short cytotoxic poly- 
peptides can be useful for their in vivo production following 
chemical or enzymatic leavage after expression. 
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